InvestorsHub Logo
Followers 14
Posts 306
Boards Moderated 0
Alias Born 01/17/2021

Re: iryokabu post# 359727

Thursday, 11/11/2021 7:57:51 PM

Thursday, November 11, 2021 7:57:51 PM

Post# of 427316
Really now; please point out all this negativity.

His comment sounds really negative about PIT 2 result



The following co-authors on the presentation might be interested as well.

Deepak L Bhatt, BRIGHAM AND WOMENS HOSPITAL, Boston, MA; andres orlandini, Estudios Clínicos Latino América, Rosario, Argentina; Alan S Go, KAISER PERMANENTE NORTHERN CAL, Oakland, CA; Andrew P Ambrosy, Kaiser Permanente, Oakland, CA; Preston P Mason, Brigham and Womens Hosp, Beverly, MA; Tabassome Simon-madjlessi, Unité de Recherche Clinique (URCEST), Assistance Publique-Hôpitaux de Paris, Hôpital Saint Antoine, Sorbonne Univ, site St Antoine, Paris, France; Philippe G Steg, Hop Bichat, Paris, France; Subodh Verma, ST MICHAELS HOSPITAL, Toronto, ON, Canada; Rafael Diaz, Estudios Clínicos Latino América, Rosario, Argentina; the PREPARE-IT 2 Trial Investigators

That's a lot of star power that signed on to this "failed" study. And they probably did not sign on till they actually saw what was being presented. That's the way it works.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News